Quarterly report pursuant to Section 13 or 15(d)

Stock Options, Warrants and Restricted Common Stock (Tables)

Stock Options, Warrants and Restricted Common Stock (Tables)

9 Months Ended

Sep. 30, 2020

Share-based Payment Arrangement [Abstract]

The Company recognized total stock-based compensation expense during the three and nine months ended September 30, 2020 and 2019, granted under the Equity Plan, from the following categories (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Restricted stock awards under the Plan	$	467	$	81	$	2,848	$	373
Stock option awards under the Plan		-		-		-		58
Total stock-based compensation	$	467	$	81	$	2,848	$	431

Summary of Restricted Plan Activity

A summary of the Company’s unvested restricted common stock awards activity in the nine months ended September 30, 2020 is presented here:

	Number of Shares		Weighted Average Grant-Date Fair Value
Unvested at January 1, 2020		1,524,499	$	1.37
Vested		(1,850,965)	$	1.36
Granted		1,544,359	$	1.27
Unvested at September 30, 2020		1,217,893	$	1.27

Schedule of Changes in Outstanding Warrants

Following is a summary of outstanding warrants that were issued outside of the Equity Plan for the nine months ended September 30, 2020:

	Shares Underlying Options/Warrants			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value
Outstanding at January 1, 2020		3,574,257		$	19.48		2.9	$	-
Exercised		(200,000	)	$	1.94		-
Forfeited		(20,000)		$	3.50		-
Outstanding at September 30, 2020		3,554,257		$	20.62		2.1	$	1,298,189

Exercisable at September 30, 2020		3,554,257		$	20.62		2.1	$	1,298,189